SEC 13F Intelligence

Aquilo Capital Management, LLC / XENE

Aquilo Capital Management, LLC’s Xenon Pharmaceuticals Inc Position

Does Aquilo Capital Management, LLC own Xenon Pharmaceuticals Inc (XENE)? Not currently — the last reported position was 1.50M shares worth $17M in Q1 2020; the fund’s latest 13F (Q3 2025) no longer reports it.

Position Value
$17M
Q1 2020
Shares
1.50M
% of Portfolio
+6.63%
Quarters Held
5
position exited

Position History XENE

Reported value by quarter
Q1 ’19: $10MQ1 ’19Q2 ’19: $9MQ2 ’19Q3 ’19: $9MQ3 ’19Q4 ’19: $15MQ4 ’19Q1 ’20: $17MQ1 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20201.50M$17M+6.63%
Q4 20191.17M$15M+5.75%
Q3 2019951.5K$9M+6.04%
Q2 2019951.5K$9M+3.26%
Q1 2019951.5K$10M+4.28%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aquilo Capital Management, LLC’s full portfolio or all institutional holders of XENE.